Healthcare • Medical Devices
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if RCEL is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
9 top institutions tracked
Last 13F trend: accumulating (heavy)
Unlock crowding heatmapUnlock filer discoverySentiment: neutral
Last trade: buy 52 days ago
Red flags: 14
74 filers reported a long position in RCEL for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $5.5M | 1.3M | -0.1% |
| BlackRock, Inc. | $2.3M | 565K | -50.1% |
| GEODE CAPITAL MANAGEMENT, LLC | $1.4M | 339.8K | -37.4% |
| MARSHALL WACE, LLP | $1.4M | 338.4K | +543.8% |
| AQR CAPITAL MANAGEMENT LLC | $1.3M | 321K | +240.2% |
| MORGAN STANLEY | $827.9K | 200.5K | +27.2% |
| VANGUARD FIDUCIARY TRUST CO | $753.3K | 182.4K | -5.7% |
| NewEdge Advisors, LLC | $615.1K | 148.9K | +71.4% |
| MACQUARIE GROUP LTD | $595.4K | 144.2K | +1,111.3% |
| STATE STREET CORP | $532.7K | 129K | -69.9% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.